EFTA Document EFTA01485243
J.P.Morgan JEFFREY EPSTEIN ACCT- For the Period 3/1/09 to 3/31109 Cash & Short Term Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation Cash 56.58480 56.610 73 25 93 100% Market Value/Cost Current Period Value Market Value 56.610.73 Tax Cost 56,610.73 Estimated Annual Income 288.33 Anefued Interest 28.57 Yield 0.47% Page 4 of 9 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00006520 S
Summary
J.P.Morgan JEFFREY EPSTEIN ACCT- For the Period 3/1/09 to 3/31109 Cash & Short Term Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation Cash 56.58480 56.610 73 25 93 100% Market Value/Cost Current Period Value Market Value 56.610.73 Tax Cost 56,610.73 Estimated Annual Income 288.33 Anefued Interest 28.57 Yield 0.47% Page 4 of 9 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00006520 S
Ask AI About This Document
Extracted Text (OCR)
Related Documents (6)
EFTA01682184
EFTA01370863
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
EFTA00014087
EFTA02367961
EFTA01977826
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.